カリフォルニア州における間質性肺疾患の臨床試験
カリフォルニア州内の拠点で、間質性肺疾患に関する22件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Southern California, Los Angeles
- Newport Native MD, Inc, Newport Beach
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of California Los Angeles, Los Angeles
被験者募集中第3相
40歳以上 · 全性別 · 2026/09/30更新 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA007, Fresno
- USA010, Los Angeles
- USA023, Los Angeles
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07179380A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Los Angeles
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Orange
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- San Francisco, San Francisco
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/08更新 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/04更新 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- HCA Riverside Community Hospital, Riverside
被験者募集中
18歳以上 · 全性別 · 2026/09/02更新 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- David Geffen School of Medicine at UCLA, Los Angeles
- University of California, San Francisco, San Francisco
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/02更新 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Santa Barbara
- Clinical Research Site, Torrance
被験者募集中第2相
18歳〜85歳 · 全性別 · 2026/09/02更新 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Cedars-Sinai Medical Center, Los Angeles
- UC Davis Health Medical Center, Sacramento
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/26更新 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University Medical Center, Palo Alto
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/18更新 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
被験者募集中観察研究
21歳以上 · 全性別 · 2026/08/12更新 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/10更新 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of California, San Francisco, San Francisco
被験者募集中第2相
4歳以上 · 全性別 · 2026/07/22更新 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Peter Morton Medical Building, Los Angeles
- NewportNativeMD, Inc., Newport Beach
- University of California Irvine Medical Center, Orange
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/07/13更新 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- The Medical Research Group, Inc., Fresno
被験者募集中観察研究
18歳〜80歳 · 全性別 · 2026/06/26更新 · NCT06129240TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of California San Francisco, San Francisco
被験者募集中観察研究
24歳以下 · 全性別 · 2026/06/22更新 · NCT04098445Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
被験者募集中第2相
40歳以上 · 全性別 · 2025/11/12更新 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Los Angeles
- aTyr Investigative Site, San Diego
被験者募集中第2相
18歳以上 · 全性別 · 2025/05/07更新 · NCT05892614Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of California San Francisco, San Francisco
被験者募集中観察研究
18歳〜90歳 · 全性別 · 2024/05/03更新 · NCT06397677ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。